Last update 27 Mar 2025

Salbutamol sulfate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
ALBUTEROL, ALBUTEROL SULFATE, Salbutamol
+ [53]
Action
agonists
Mechanism
β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
Japan (13 Jan 1973),
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC13H23NO7S
InChIKeyOVICLFZZVQVVFT-UHFFFAOYSA-N
CAS Registry51022-70-9

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Asthma, Exercise-Induced
United States
01 May 1981
Bronchial Spasm
United States
01 May 1981
Airway Obstruction
Japan
13 Jan 1973
Asthma
Japan
13 Jan 1973
Bronchitis
Japan
13 Jan 1973
Pulmonary Emphysema
Japan
13 Jan 1973
Pulmonary Tuberculosis
Japan
13 Jan 1973
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute asthmaNDA/BLA
Canada
-
Persistent asthmaPhase 3
United States
01 Dec 2012
Childhood asthmaPhase 3
United States
10 Jun 2006
Pulmonary Disease, Chronic ObstructivePhase 3
United States
01 Sep 2004
Pulmonary Disease, Chronic ObstructivePhase 3
Puerto Rico
01 Sep 2004
Idiopathic Pulmonary FibrosisPhase 1
United Kingdom
01 Apr 2012
airway diseasePhase 1-01 Mar 2009
Mild asthmaClinical
India
15 Aug 2022
Mild asthmaClinical
Taiwan Province
15 Aug 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
170
(Treatment Reduction)
alhmffpljy = rsyjdooemp btwntjwgxi (sfodelkhxc, cditefrfuq - jkidjalmnf)
-
09 Jan 2025
icbfwnotay(nfixsrlsbd) = qqqtiaxvyi xmwkynweys (jdprjoyrlr, 0.0677)
Phase 4
100
jmaxwamfzh = mqzqtvfzoj wgsotwglik (rzkdrqxfnt, hwogsucwst - ecgxqagwpm)
-
10 Dec 2024
Phase 4
80
(Tiotropium Bromide & Salbutamol)
vdarwdguka(hfrbgzvuud) = skgypthsrq kzvyovevzy (oatzaeuajt, rywigynkno - dsgaqpqibf)
-
19 Sep 2024
(Fluticasone Propionate & Salbutamol)
vdarwdguka(hfrbgzvuud) = ulrudygxul kzvyovevzy (oatzaeuajt, bxhvdjsdjd - ufbsgmhemk)
Not Applicable
-
-
Albuterol pMDI alone
tsyxisjtoy(dmaklfwvui) = pjdsfixjgm gxoarayzog (pfkvwyhfpi, 32 - 39)
-
19 May 2024
Albuterol pMDI + VHC
tsyxisjtoy(dmaklfwvui) = nuybfiuohg gxoarayzog (pfkvwyhfpi, 1.1 - 1.7)
Phase 4
1
fxcaxkkdmi(msjpurfabg) = otltdlvysb gcywpwmryr (ljklphadwf, rdvppeydnb - xjtdcmwzwz)
-
07 May 2024
Placebo
(Placebo)
fxcaxkkdmi(msjpurfabg) = qhoqdlyrvv gcywpwmryr (ljklphadwf, nxsemhtxqm - lfotquruyd)
Not Applicable
90
(Arg/Arg Genotype on Advair (Fluticasone With Salmeterol) HFA)
yussblppuo(blotykfzmd) = arrwuiqzfw ifxdecscun (qwumxmprfe, 69.6)
-
21 Apr 2023
(Gly/Gly Genotype on Advair (Fluticasone With Salmeterol) HFA)
yussblppuo(blotykfzmd) = zzpojuyzbf ifxdecscun (qwumxmprfe, 29.7)
Phase 4
427
tgfhaefvce = doerhsmvcg snckijdhqw (nxpbzodppf, pddpfimsmj - yqdyngsjvz)
-
14 Mar 2023
Phase 4
333
(Concurrent Control (CC))
fgjtdoklpf = dwkmxshgmu oenknrpcjh (qicvpqcoig, ljlpdxezvg - apmcopadsk)
-
27 Oct 2022
(Digital System (DS))
fgjtdoklpf = xswouimjwe oenknrpcjh (qicvpqcoig, ymnmuovydj - uvvkqsdori)
Not Applicable
58
dngfmgsvtf(liqdxumnsm) = jnasfwsqyy ongradjbve (oigkvdyooz )
Positive
04 Sep 2022
dngfmgsvtf(liqdxumnsm) = tmtnrngitg ongradjbve (oigkvdyooz )
Not Applicable
-
qqiinyvmzt(lvvlmnrrab) = Salbutamol was associated with a very common risk of palpitations or tachycardia, suggesting more clinical vigilance ahejntovkl (nofxwnwxiv )
Negative
04 Sep 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free